6-(3-Bromophenyl)-2,3,4,5-tetrahydropyridine

ID: ALA3759225

Chembl Id: CHEMBL3759225

PubChem CID: 127024854

Max Phase: Preclinical

Molecular Formula: C11H12BrN

Molecular Weight: 238.13

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Brc1cccc(C2=NCCCC2)c1

Standard InChI:  InChI=1S/C11H12BrN/c12-10-5-3-4-9(8-10)11-6-1-2-7-13-11/h3-5,8H,1-2,6-7H2

Standard InChI Key:  IAPFRWYGZQXILQ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3759225

    ---

Associated Targets(Human)

CHRNB4 Tclin Neuronal acetylcholine receptor; alpha3/beta4 (2283 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chrna4 Neuronal acetylcholine receptor; alpha4/beta2 (3557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna7 Neuronal acetylcholine receptor protein alpha-7 subunit (3047 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 238.13Molecular Weight (Monoisotopic): 237.0153AlogP: 3.42#Rotatable Bonds: 1
Polar Surface Area: 12.36Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.02CX LogP: 3.21CX LogD: 3.19
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.71Np Likeness Score: -0.73

References

1. Matera C, Quadri M, Sciaccaluga M, Pomè DY, Fasoli F, De Amici M, Fucile S, Gotti C, Dallanoce C, Grazioso G..  (2016)  Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype.,  108  [PMID:26706350] [10.1016/j.ejmech.2015.11.045]

Source